6
June 1 2006 R EC E I f M f I II JUN 0 1 2006 Ms Barbara Dombrowski AHCA 2727 Mahan Drive MS 51 Tallahassee Florida 32308 liUM j OF LO 1GTED llli i l r t i 1 n lI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience over the past year at Santa Rosa Health Rehabilitation Center in Milton Florida Thank you Ms Dombrowski for your support and guidance throughout this process and thanks to AHCA for this grant program as the results speak for themselves The Anodyne near infrared machine has proved to be a valuable treatment tool to reduce pain reduce swelling increase sensation and improve function for a variety of patients The format for this report reviews the operational overview clinical outcomes in terms of qualitative and quantitative datum alternative treatment options and some general observations The attached Table 1 describes individual patient treatment outcomes and patient comments Operational Overview Orientation to the machine involved an initial three hour training conducted by a variety of highly skilled Anodyne representatives Use of the machine proved relatively simple A Apply a protective barrier saran wrap on the skin over the chosen sight B place the pads that emit light on the chosen sight over the barrier C turn the machine on and adjust the intensity according to desired use and D leave on for 20 30 minutes each treatment The training suggested that measurable results would take a minimum of 12 treatments The mechanism at work is basically twofold The light emitted acts to dilate blood vessels and provide gentle warmth These two features result in increased circulation decreased pain and increased sensation which in turn produce better functional capabilities Patients were seen either three times per week or five times per week depending on the individual plan of care There are only two conditions for which the Anodyne may not be used pregnancy and active cancer Clinical Outcomes The attached Table 1 describes the relevant outcomes and patient comments The key defines the column headings however a review is appropriate Patients are numbered to maintain confidentiality Diagnosis reflects the reason why therapy was involved Treatment dates reflect the weekly documentation required for those being treated by Anodyne Candidates were 1

liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

June 1 2006

REC E I f Mf III

JUN 0 1 2006Ms Barbara Dombrowski

AHCA2727 Mahan Drive MS 51Tallahassee Florida 32308

liUMj OFLO 1GTEDllli i

lr t i

11 nlI l f

Dear Ms Dombrowski

The purpose of this letter is to furnish a final report of the Anodyne experienceover the past year at Santa Rosa Health Rehabilitation Center in MiltonFlorida Thank you Ms Dombrowski for your support and guidance throughoutthis process and thanks to AHCA for this grant program as the results speak for

themselves The Anodyne near infrared machine has proved to be a valuable

treatment tool to reduce pain reduce swelling increase sensation and improvefunction for a variety of patientsThe format for this report reviews the operational overview clinical outcomes in

terms of qualitative and quantitative datum alternative treatment options and

some general observations The attached Table 1 describes individual patienttreatment outcomes and patient comments

Operational Overview

Orientation to the machine involved an initial three hour training conducted by a

variety of highly skilled Anodyne representatives Use of the machine provedrelatively simple A Apply a protective barrier saran wrap on the skin over thechosen sight B place the pads that emit light on the chosen sight over thebarrier C turn the machine on and adjust the intensity according to desired use

and D leave on for 20 30 minutes each treatment The training suggested that

measurable results would take a minimum of 12 treatments

The mechanism at work is basically twofold The light emitted acts to dilate

blood vessels and provide gentle warmth These two features result in increased

circulation decreased pain and increased sensation which in turn producebetter functional capabilities

Patients were seen either three times per week or five times per week dependingon the individual plan of care There are only two conditions for which the

Anodyne may not be used pregnancy and active cancer

Clinical Outcomes

The attached Table 1 describes the relevant outcomes and patient comments

The key defines the column headings however a review is appropriatePatients are numbered to maintain confidentiality Diagnosis reflects the

reason why therapy was involved Treatment dates reflect the weeklydocumentation required for those being treated by Anodyne Candidates were

1

Page 2: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

treated either three or five times per week Pain Scale defines pain on a scaleof one to 10 One is very minor pain 10 is the worst pain imaginable Naturallythe lower the pain the better Flexibility measures how much a joint can move

measured in degrees 90 degrees is a right angle For example to put on a shirt

a person needs about 130 degrees of shoulder movement Sensation againthe more the better Function therapy intervenes based on the inability of a

patient to perform some kind of functional activity Whether it be walking to thebathroom or getting dressed the goal of therapy is to help people do as well as

possible in daily life Patient Comments are the quotes supplied to the

therapist throughout each treatment week

One feature of the Anodyne treatments that is not reported is the reduction in

pain medications required for comfort While Table 1 describes pain level

reported by the patients reporting the reduced need of pain medications was an

oversight that is not included Patient interviews performed intermittentlyreflected a highly significant decrease in pain medication use Common was a

person that had to have 3 or 4 percocets per day to manage pain Following a

week or two of Anodyne this would drop to 1 or 2 per day and in most cases

down to zero need for percocet following a month long regimen of Anodyne15 patients were treated with the Anodyne over the past year 14 of the 15

patients reported significant or highly significant improvement in function that was

attributable to the Anodyne application The remaining candidate discontinued

use for lack of perceived benefit

The Anodyne proved most effective with individuals with peripheral neuropathyand wounds

Rather than requiring 12 treatments to elicit measurable progress as the trainingindicated many candidates experienced positive side effects after only a week or

two worth of treatment Other indications were that it felt soothing and warm

With respect to other treatment interventions attempted in the case of the two

premature discharges massage and gentle range of motion was attempted with

equally fair results The Anodyne machine represents a different approach to

treatment Modalities such as electrical stimulation and ultrasound have different

applications and as such were not appropriate in these situations Othermodalities such as diathermy were not available for comparison Typical plan ofcares for these candidates included gait training activities of daily livingtherapeutic exercises therapeutic activities and neuromuscular re education

The apparent ability of the Anodyne to help restore circulation and sensation sets

it apart from other applicationsThe overwhelming sentiment of patient feedback was positive and in most cases

came as a surprise to the patient that anything could help reduce their pain or

improve sensation as many had just learned to live with the pain or numbness

2

Page 3: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

General Observations

Initially therapist acceptance of the Anodyne was fair Much skepticismaccompanied questions during the training sessions The tide turned however

after therapist started using the Anodyne and patients began reporting goodresults Therapist began trying it on themselves and found positive results

Following the success at Santa Rosa the parent company purchased an

Anodyne unit for each of the remaining buildings The Anodyne have proven to

be a valuable treatment tool to help people heal and feel better While it is not a

panacea the Anodyne does have a very positive impact on most people and is a

worthwhile addition to any therapy program

Again we thank AHCA and yourself for the opportunity to participate in this grantprocess and we look forward to future collaborations in an effort to improve the

lives of the people we serve

7lZKen Leeman

On behalf of Renita Enfinger AdministratorSanta Rosa Health Rehabilitation Center5386 Broad Street

Milton Florida 32570

3

Page 4: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

0

liD w

CIl11

CIl 0l 0 0 r

Q0 1 1 Ql 1

T l 0 5 toCIl Cil

j 10 l poC

Ql

eto 0 CIl

1CIl l 1

01 5CIl

INU1

CilQl

3N N1 N

l N N j NOi 0ii j 0 IN 0 J

N N N N N N N0

N0

0 0 0 0 0 0 00 0 0 0 0 0 0

01

Ol Ol Ol Ol Ol Ol OlOl

0

CilQlCIl10

e0 INC IN 1 J U1 jl 00 CIl CIl 0

00 0 0 0

CIl Ql Ql S S S S S SN 3 3 a a 0 a a1 1 1 a

0 0 0 06 0 0

e10

0

liD

0 z z z z z z z z

CilC3

0

3

III 01 J l0 Ql 0 0 01 0 01 0

F 3 F F FCl

0 0 0

J J J J J J Ji5 i5 i5 i5 i5 i5 i5c c c c c c c

1O 1O 1O 1O 1O 1O 1O

rrJ l J 010 0 0 01 0 01 0

F F F F F0 0

1O 3 3 3 3 3 3iil x x x x x x

Cl Cl Cl Cl Clc a a a a a

1O 1O 1O 1O 1O 1O

0 iil iil iil iil iil iilc c c c c c

Cl0 0 0 0 0 0

ClQl

roe CIl CIl III 0 CJl CIl

Ql Ql Qlii 0 Ql

3 3 3 3 3Q1 1 1

0 1 10

ii ii5c Cil Q1 0CIl c 50 n CDf 0 n

l 0l

j3

ci3 s

Ql 0Ql l 1

e0

l 10 00 1 TQl 0Ql 0 CIlto 5 c ii0 5 l0 5 to l

C to 3 ii0 e

0 ii c0

CIl 3 c Ql1 0 03 to0 1 1

3CIl 0 00 e 5c 0

0 l to to

0 CIll 3

0

liD

N

CIl11l 0 Z

Q1 1l C

j 0TI 0

e Ql

1 c T1

CilINU1

CilQl

3N1 N

l N NCiiii J U1 co

N N N N N N N0 0 0 0 0 0 0 0

0 00 0 0 0 0

1 Ol OlOl Ol Ol Ol Ol0

CilQlCIl10

0Ql

5 U1 U1 U1 Ol j co0

0 0 0 0 0 0 0

6 S S S S S S se a a a a a a a10

Q0 0 0 0 0 0 0

to

Cil 3 3CIl CIl CIl CIl

Ql Ql Ql 0 Ql lU 0 3 3 3 30 0 1 1 1 1 10

3 5CIl

1 1 00 00 0

Ql Ql Cil 11

3 ll Ql

CIl

Sl1 10 10 1

ill ill 10

0Ql l

l l to0 to to 1

Cil1 1

CIlCIl CIlCIl l l 0 Ql Ql

CIl 0 0 13 3

0N Cil Cil @ CIl

0 1 1 1Ql Ql Ql

Ql CIl CIl CIllr 1 1 1 50 0 0 0

Cil N CIl CIl 00

0 1 1 Ql 0

l l 5 T0 III CIl

l l l CDill 0 0

gl l

CIl

iii

10CIlCIl

e CJl l C C

0 Ql Ql Ql 0 Ql l l

3 Cil l Ql Ql0 0

5II CIl 1 Ql CIl

10 10e e

CIl iii0 1 l 0 0Cil 0 0

Qle CIl

CIl e eCIl iii Ql Ql1 Ql 10 l Ql

1 0 CIl

Cil 5 CIl

to ii

50

Ql iiiQll0 5 @1

01l0

31CIl e uf CIl el 0

0 lQl 0 to to Ql 0

c 1 0 0C

1 0CIl 0

50 c

l 0 S0 to

0e 1 0 T 1

1 c CIl Cl 1 0O l iii CIl

e Ql l Ql to

III QlII 0 3

to 3 Ql eIII

5 5 c to

cp0 Ql 0

lto

0

liD

CIl11l

QIN

e11

CIl

U1

CilQl

3 Z Z Z

10 0 0

l

CD en CD0 0 0000

l l l1 1 10 0 0

30

o131

5CIl1lCIl

l0

l

6e

0

T10

liD

o 5CD 8

1III

CD

Qll0

301Jl1Jl1Jla en Q Q

m m m1 l l l

@ @ @Ql

oCIl

iiil0

Z Z Z

Zo 0

o CIl

II 1CD Q al lCIl to

l 1

0l

W 0 0

Q Q

000Ql Ql Qll l l

CD CD CD0o33CD

l

Ul

3

0fa

3

III

5

CDl

iiil

o Z

c

aa g@ T

ciii

cel

oUl

iii

I

iJDl

3CDl

C

l

jj

016 ene CD

lUl

1 DlCIl

cil

3

CD

TIC

lo

o

clCl

cil

TIQ lQl TIto 0

gIN

Ql 0n CIl

CfJ

la cr0 l

e0c

C c5p g5e ro3 CIlc 1

o lCIl

la cT lCD r

n IN

o aQl U1l

0III m

@

a ro 1

o 0J

T1

ine II

l

1 CIl

CD c5CIl

l

CIl e1 00 C

5 cC1 0

@s CDto 101 CIl

CIl

CIl

TI

Q CIl

1 lx 0

3 l0 T

IN

0CIl1lCIl

l0

tlDl

iiil

CJlIlCIl

ol

o1III

g01CIl

o

e

3co

Ql

0

CIlol

oQll

CD

5Ql

to

C1

l

0o0

UIII

ml CT1 0

o

iieill0rcoco1 1l l0 01 10 0

0o

01to

Cil1CIl

eoc

c01

Ql

CIl1III

r0o

0o

0l

0rQllto

10QlCIl

e

TI

10

g

1QlCIlC

o Cilii 0

eill0r

501to

Cil1CIl

QQl

to

C1

l

0Ql

5

a

3o

131

01

a310

Ql

nC1

0

0

liD

3IIIto

5Ql0

eD

TIQ1XQl

30

o

oiii

cel

oCIl

ii

EgJJ

CDliio0 Co

NOollICD

lRsQo

oCCD Qr

cCDCo

ill31

e

1l

lo0

l1

eQlCIl

CCIl10

Cil0o

l10

oCilCIl01

n

Page 5: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

lJ

liiia 0

Vlroro

Z

Qro ne 0

CD 0 T

0 2E Ql 0ro gro1Vl

J01

iilQl

3J Jro

JN N J N 0 NCD JN

0 0 N NN N N0

N N N 0 0I 0 0 0 0 0 0 0 0 0Ql 0 0 0 0 0 0 0 0 0a 0 0 0 0 0 0

0

eVlro

Vl Vl Vl Vl Vl Vl Vl

a Ql Ql Ql Ql Ql Ql Ql I

3 3 3 3 3 3 3 QlTQl ro ro ro ro ro ro ro a

Vla QlVl

iillro e

3l 0

0en

0 0 Vl Vl Vl Vl 00 3 0 0 0 0

33 0 Z 3 3 3 3 ii ro0ro iil ro ro ro ro ro

ro 3 3 3 33

en en Ql0ro 0 0 0 0 Ql Vl

e e 0 0 0 0 0 VlVl roro n Ql

ro ro ro ro g ro0 0

T3 3 3 3

xQl 0 e 0

T ro ro ro ro ro 3l a a a a aQl Vl 0 aea VlVl ro

l a Vla T 0

0 Ql I 3 z

Ui Ui ro 0a

a 0Vliii iii ro gl g g

rom0

aro ro 0 J

0 Vl Vl Vl Vl C1l

Ql iil Ql Ql Ql J

en 3 Vl 3 3 3 f0 0 Vl0 0 0 ro e ro ro ro 03 g g iilro T T Vl J

E Ql Ql ro Tw

ro a a VlQl a1 Vl Vl l

0roVlVl

iil J tD z3 w w 0 C1l W W C1l W

a 10 C1lQl C T J J T a

or 0 10 0 2J

2a or J a T

10 C C1l afil T J 10 C 0 mw J 6 or J

a T 0 JC J J

0 J0 c T

2 J T 3J T C1lT C1l I C1l J

T 0W T T TC1l W

C1l Wa

0 aTw

0a

3 33 0 0

iil ro ro Qla 0 n Ql iil roVl 0 ro 0 a

Qe

3Ql

eVl Ql a T0 ro

ro ro Vl

l 0 ro 3Vl

Q i5 ro

c ii Ql 0 3ro 0 E a gT TgQl Q ro T

0 E QlVl 0 ro a iil c

0 ro Vl g 0 a

0 po Ql Ql0 0 Ql 0

0Ql 0 0

s0

iil ro

3 g roro

3 T03

0

lJ

liii

0aVlroro

i0

Q 0 iiie 0

roa en

E Vlroro1Vl

01

iilQl

30 0ro 0N N 0CD 0

NN N N00 0 00

0 0 0 0 0

30 0 0

0

iilaa0Ql 01 0 CD

0 0 0

iil s s Sa a a 0e

@a

0 0 0

03CD

0 Z

S o

a0 z z z

0 3

l 2iii

ro al

001 iil0

Ql

3 zs o

aro Ca a0 m

0 iil 0l C1la

0J

0 en en C1l

a Ql Ql

3 3J

c fro ro 0

0g3

Ql5

0cro C1l

C1lg J

ro

iil0 w

J J2

nCD

CDm

w

1 s sTro

0 CD0 QllQl

iiT

ii e

0 30 e

0

0T Vl

a0 iiiro

0poE

Vl

roro0

0

l

lJ

liii

coaVlroro

0 0

Qro s0

e l lO

9croiil1

Vl

01

iilQl

3 a

ro 0CD

J 0 00T N N0 0

en Vl 0 0ro 0 0 01J 01

Vl

l0J

0

iil 01 CDQlVl 0 0

ro s sa

a a03 0 0

J

0Jro

lro

l

0 z Z

I

Ji

Vl ZQl 03 iiiro

groVlroJVl

l0

J IC1l xw Ima

3

0c

a

sE

0Ql

0 a Je 0 Vlc n ro

Q ro

ro g T

0 ro

iil1 lVl

Vl

iii 3a

E 0

Tro 0J0

iil0

l0Ql0

lJ

liii JaVlroroJ Z 0

Q ro iiie 0

N 0 ro

E0 enQl Vl

ro gro1sVl

0

iilQl

3CDro

J N0

N N0 0

0 0 0

301 01

0

iil

ai I

a0Ql 01

0 0

iil s sa 0 0e

@a

0 0

a301

0s

az z

0

lro

l

0

0s

a0

la

0 z z

7 nw w

J

0 2If

a 0

aC1l

mwJ

C1la

CwJ

F70QlJ J

Vl J

iii gVlaiii

e0 a

E e

s 0

0 0

s ro0Qle

T Vle C1l

30

Vl CD0 l3 Te e0

r

lJ

liii 0aVlroroJ lJ 0

QQl iii

0

I ro

enE Vlroro1Vl

N0

iilQl

3oJ oJro CD

J N NCD

N N N N0 0 0 00 0 0 0001 01 01 01

30

iila0

0Ql 01 CD

0 0 0 0

iil s s s sa a a a ae

@a

0 0 0 0

03CD0

s

az zz z

0

lro

l

0

0

s

a

0

la

0z z z z

0 0 Vl lJro l Ql Ql

3ro

s VlVl ro enro roro 00 iil

Vl

Vl

roro0

3s0 0

Ql Ql

3 J 0 JQl

e Vl J0 ro gT ro ii0 0 Vl

l l 3 roe ro

J 0 0

cO T lr 0

roQl cO0Ql

lJ

liii

OaVlrorol 0 tJ

0 0

Q s iia

roro 0

t Ql roI 0 Vl

E Ql ro

ro 2 lro c1Vl ro

N

iilQl

301ro 0 0J 0 N N

N N0 CD N

N N N0 00 0 00 0

0 01 01 0 0 0

301 01 01

0

iil

aa0Ql I 01 0

0 0 0 0 0

iil s s s s sa a a a a 0e

@a

0 0 0 0 0

0

30

0

so

Z Z Z Z Z0

lro

l

0

0

s

a

0

la

0z z z z z

If J J Ulw 0 wcO

T 3 3 3C1l C1l C1l 5C1l C fil0 W

W J aJ

m Qj8 a

3c

C0 0 ww 0 Jma

6 C1l

fJ J0 10

s 1Vl T E

iii 0 Jro 0

iil e

E 3 Vl cCD 0

Ql0ro ro ro

fii 03 03 l ro

roe iiia

0 lT E0 0 iill l J g

0

gs0

Ql WJ

a

0

lJ Cl DIiii

ja CDVlroro

VlJ lJ Z 0

Qro 0 ro iii eJ Q eVl

00

DjCD l roro

0 en ccE 0 0 Ql Vlro J gro 01 UIVl

iiI0

iilf

Ql CD

3 DI

ro CD CD 3J 0 N N NUi oJ 0 0 CD

N N N NN N

Z 0 0 0 0 0 00 0 0 0 0 0 0 e0 0 0 0 0 00 DI0

3 CD0 UI

iil

jj0 0 I 01

0 0 0 0 0 00 s s s s s s CQl

a a a a 0 0

la

0 0 0 0 0 0

0

TICD

Z Z Z Z Z Z

2

G0 00 N Vl

a Ui Ui Ui Ui ro

0 aJ r r r r

0 0 00

I Ui Ui Ui Ui g U

M CDCD

QlUIDI

0

0 Ui 0J

rN

Ji

z z z0 C1l 2 2w w JC J

w ww J J C 0 0J

5 J w m mT 5

6 6 TI10 00 l

a C1l

iil W W

0 CT J fC1l 0g C1l C1l

J Iff w

co fT

C1l 00

0 s Ca T

CD0 E DI

cQl Ql 0

ro CD J e CD0 ro fii l J cQl J

0 0CD1 E 0

CD 00 ro8 Ql a

00 0g ro 0 l 3 0 3ro a

E e 0 3g Ql 0 00 ii i TQl CD

a 01

T UIiil 0

Ql J 3

0J0

3

Page 6: liUM 1GTED r t i 1 nlI l f l - FL Agency for Health Care ... · 1 nlI l f Dear Ms Dombrowski The purpose of this letter is to furnish a final report of the Anodyne experience

n

0 TI

iii0 Ui1etVI T

0

31

tT

ii0So 0

b 0 0N N

ii 0000J1J1

0

0J

iilC3

z

0 0

0 0III III

l 500III

Inet5 III

30 1iii JJ

0 eJ

n0III 0iil J

III

3

rIu1

VI III 01 30 VI0 1 1J J0 VI

E1 01 J

50 0

50

r

r it1

ill0

I

e

0CD

Ui

20 s0

00

E0

III QE

0 IIIJ

e etVI 01

III 30 1

III 0JTIII

1

J00

J

tl

ii

VI11J OJ 0

Q0 0 ii Nr 1 T

0 ill CDIII 1VI 3E n 0 1

III 1 VI

III 0VI

7VI

0

iilIII

31 0 0 0 0J Ui N N 03il 0 N

J1N NN N 0 N N 0 00 0 0 0 0 0 0 0

J 0 00

0 0 00 01 0 0 0 0 0

1VI

IIIJ0

T

0VI z5 VI VI VI VI VI VI VI

0J

III III III III III III III

3 3 3 3 3 3 3 11 1 1 1 1 1 1 aIII

x

0J

JIII

Ic0 0 0 0 0 0 f0

III7 3 3 3 3 3

III0 VI III

CDJ III f1 0 0 0 0 0

0 1 3 3 3 3 3 3 rootl VI 1 I1 0 1 1 1 1 1J 0 3 3 3 3 3 0

T 0 1 1 1 1 1 f

III 1 00

EIII

0

r cJIII0

CDVI VI VI VI VI VI VI 0III III III III III III III

3 3 3 3 3 3 3 0

1 1 1 1 1 1 1 1

et351

J 0 III 3 III 0 tii 0 III 0 0 iil0 0 CD r 0

1 J 0 III0

0 1 e 3 ill 33 1 20

0 0 J r et 1

lIII 0 ii 0iil a

10 ill 5e Q r0 r iii5 J0 r 1

et 0 1 etii

0 0 it 00 0 0

iil e T J 0iil

J 1VI ii 0 iilIII 0 1

e E 0 0n 1 a 1 III

eVI VI0

iil 0 e 0 1

iiVI J 0III

51

VI J 3 0 0III

a 0 0

5 iil1 iil 0

0 r F III 01 VI 0 T

iil 0 1 JIII r c 0 0

VI iil g1 e

0 ii J a5 1 0 0 10 0

J E1

III1

E IIIJ 1 iil ii VI0 X

E J0

it0

iil 1 VI 3i riil 00 ii ill 0 00 J e

il3 J VI 0

00

2 r0 1 00 iil 5 CDJ a5 CD 1 c 0

0 VI III 3 III VIVI

J

00

J

tl

iiVJ

VI11J Z 0

Q1 iiie 0

I 3 1

E0 etIII VI

1 r17VI

VJJ1

iilIII

31 0

0 0 0J Ui N N 03ii 0 N

0 J1N NN N 0 N N N 0 00 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0 0e 0 0 0 0 0

aJ

EIII

z1

VI VI VI VI VI VI VIIII III III III III III III e3 3 3 3 3 3 3 31 1 III 1 1 1 1 0

IIIJ0

00e

aEIII

z z z z z z z z

0

r

z

III 0

J VI

it III 1J J

VI

Iiiit

VI VI VI VI VI 0g III III III III III J

CD 3 to 3 3 3 3 01 1 1 1 1

1VI 01 0J EVI e

70T J

0 1

J 1VI

0 0 0 0 0Ql iii iii iii Ql Ql Ql 0

Iii or or c

f f f f a

@ 2 @ f Iii0 J Sq 3 3 3 0 a

l0 a Ql

a a a iiic or l5 5 5III 0 co co III

@1 f

ro

5

s i3 3T VI 0 VI

0IIIJ iil CD 3 J 0 J

III7 III 0 e 1 0

50 VI 0 E 5 III0 0 T 0 0 VI ii0 0 0 0 0 0 03 1 III0 0 10 T iii

eTl 5 T0

ii 13 J

3III5

III l

eIII

tl

iiN

VI11

rJ tl

Q1

00

E0 0

E e

1 J1 07 VIVI

0

iilIII

3I 01 0 I

J 03 N Ui Nii J1 I 0N N N N N N N0 0 0en 0 0 0 0 0 0 0 0

0 0 0 0 0 0 0 0 0

J0 0 0 0 0

0III

iil0e

n0 0J CDa 0 0 0 0 0 0 0 0

E0III

0 5eJ0

VI

N1IIIJ0

0 Z Z Z Z Z Z Z ZIII

0ii0TIII

10

T0

3 0 0e eJ J

0

VJ J1z z z z z z

x x

N 0x

N J10 0

3 3VI VI

OJ 0 0 0 0Ql iii iii Ql 0Ql Ql Ql cC or or

f af f fl8 2 @ fl orQ J S

s 3 3 0 aC l5 a Ql0 Ql a a iii

or l5 5co co 1

l 2fl

s i3 3 3VI 0 VI

00 iil CD 3 J 0 J0 1 0

III

5III 0 e

E 5 50 VI 0 III0 0 T 0 0 VI ii

T 0 0 0 0 e O 00 1 3 III3 0 0 1

0 T iiieTl 5 T

0ii 1

3 J31

5III lVI

0III

tl CIII

iiiii

VI l1IIIJ Z 0

Q1 iii ee

30

iiiVJ

10 et C

E III VI l1 r 017 fIVI

CiiJ1

iilI

III CD

3 III

1 J1 3J jii 0 CD

N N N N lt 0 0

0 0

0 0

iil0 0 0 0 e0 0

III III

3 CD1 fIJ

c

50

co C1 z z z Z0 III

jJ00

J1

IIIJ

t0 N0 III

ill T1III TI TI il iDeIII 3

ill ill iii0 0

gJ J J CD0 0 0 1

III 1 1 ill 3r J 1

0

TI1

e

eVI1

a rT aIII enJ fl

en0 1CD

VI VI VIfl

ll0 III III III0 fI

r 3 3 3 III1 1 1

0cO 0

lJQl

a

0 OJ Z 0Ql 1 1 al 1J a

0fl fl

a Q J 5co c 1 5 T1i5 coQ e fl sfl lfl c

l0

5 oJ 0

lQl

0a51f

CVI 0 VI 0 III

III III

3 J 0 J iiie 0

1

0 0 T lT VI 5 0

0 1 0 a3

0 0 0J

3T 0III 3J III

0 J CD

J S l0 T

E 5 fI

0

Es3

0

TIIIJ